After Nearly 800% Explosion, SK Hynix Debuts on Nasdaq
South Korea’s memory-chip giant SK Hynix plans a Nasdaq debut with a roughly $29 billion offer, aiming to test if AI-...
What Not To Do When Budgeting
Understanding what not to do when budgeting is crucial for financial success. Learn the common mistakes to steer clear of.
26,044 articles
Prediction: Following Alphabet, This Could Be AI Stock
Berkshire Hathaway under Greg Abel signals a sharper eye for AI champions. Could Alphabet be the catalyst, with Nvidi...
Ex-NASDAQ Warns SpaceX Lockup Could Shake Markets This Fall
A former NASDAQ chief warns that SpaceX’s unprecedented lockup could unlock roughly $800 billion in stock by October,...
XRP’s Chart Doesn’t Lie: Rival Analysts Debate the Next Move
As XRP stabilizes near the $1 mark, analysts split on whether the chart signals an imminent breakout or a renewed pul...
Rambus Tailwinds Here’s Still: Stock Neutral on AI Wave
Rambus rides AI infrastructure tailwinds but keeps a neutral stance as investors weigh valuation against accelerating...
Base Tops Ethereum in Stablecoin Volume on Payments Shift
Base edges Ethereum in June's adjusted stablecoin volume, signaling a shift in crypto payments rails and spotlighting...
Thousands Wrote About Quarterly, Exxon CFO Letter Shaping SEC
As earnings season kicks off, public comments surge over the SEC's bid to allow semiannual reporting. ExxonMobil's CF...
Synergy Take Over Newrez Reshapes Retail Mortgage Market
Synergy One Lending will absorb Newrez's distributed retail mortgage operations under a strategic agreement, extendin...
Genius Artificial Intelligence (AI) Stocks to Buy Now
AI stocks have cooled, but durable leaders still offer big upside. This guide highlights three genius artificial inte...
ARKX Aerospace Showdown: Which ETF Is a High Flier for 2026
Two funds sit at the edge of space: ARKX and PPA. This guide breaks down what each ETF targets, how they differ, and ...
IBB: Which IShares Healthcare ETF Is Right for You
Two popular healthcare ETFs—IHE and IBB—offer very different routes to exposure: established pharma vs biotech innova...
Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status